These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 28945224

  • 21. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
    Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Reyes-Núñez V.
    Acta Haematol; 2000; 104(2-3):124-7. PubMed ID: 11154988
    [Abstract] [Full Text] [Related]

  • 22. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.
    McNamara S, Nichol JN, Wang H, Miller WH.
    Leukemia; 2010 Apr; 24(4):729-39. PubMed ID: 20200558
    [Abstract] [Full Text] [Related]

  • 23. Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid.
    Gallagher RE, Said F, Pua I, Papenhausen PR, Paietta E, Wiernik PH.
    Leukemia; 1989 Nov; 3(11):789-95. PubMed ID: 2554072
    [Abstract] [Full Text] [Related]

  • 24. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.
    Komura N, Ikeda Y, Masuda N, Umezawa Y, Ito K, Kizaki M, Umezawa K.
    Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653
    [Abstract] [Full Text] [Related]

  • 25. CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells.
    Si J, Mueller L, Collins SJ.
    J Clin Invest; 2007 May; 117(5):1412-21. PubMed ID: 17431504
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
    Meani N, Minardi S, Licciulli S, Gelmetti V, Coco FL, Nervi C, Pelicci PG, Müller H, Alcalay M.
    Oncogene; 2005 May 05; 24(20):3358-68. PubMed ID: 15735696
    [Abstract] [Full Text] [Related]

  • 28. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG, Caron PC, Miller WH, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP, Scheinberg DA.
    Leukemia; 1995 Feb 05; 9(2):244-8. PubMed ID: 7869759
    [Abstract] [Full Text] [Related]

  • 29. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.
    Cancer Res; 2000 Apr 01; 60(7):1824-9. PubMed ID: 10766166
    [Abstract] [Full Text] [Related]

  • 30. Retinoic acid and its rearranged receptor in the treatment of acute promyelocytic leukemia.
    Miller WH, Dmitrovsky E.
    Important Adv Oncol; 1993 Apr 01; ():81-90. PubMed ID: 8389321
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F, Testa U, Fagioli M, Barberi T, Masciulli R, Mariani G, Peschle C, Pelicci PG.
    Cancer Res; 1995 Jan 15; 55(2):440-3. PubMed ID: 7529139
    [Abstract] [Full Text] [Related]

  • 33. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M, Guidez F, Delva L, Agadir A, Degos L, Chomienne C.
    Bull Cancer; 1992 Jan 15; 79(7):697-704. PubMed ID: 1334741
    [Abstract] [Full Text] [Related]

  • 34. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.
    Nature; 1998 Feb 19; 391(6669):815-8. PubMed ID: 9486655
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K.
    Cancer Res; 1994 Apr 01; 54(7):1746-52. PubMed ID: 7511050
    [Abstract] [Full Text] [Related]

  • 38. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J, Kantarjian H.
    Sangre (Barc); 1993 Oct 01; 38(5):375-8. PubMed ID: 8140499
    [No Abstract] [Full Text] [Related]

  • 39. ATRA(ouble) in the treatment of acute promyelocytic leukemia.
    Ozpolat B, Lopez-Berestein G, Mehta K.
    J Biol Regul Homeost Agents; 2001 Oct 01; 15(2):107-22. PubMed ID: 11501968
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.